Safety Protocols
Bloodwork schedules, risk factors, and mitigation strategies. Research-referenced.
Monitoring Guidelines
Bloodwork Monitoring
- Get baseline bloodwork before starting any cycle
- Monitor CBC every 4-6 weeks for elevated red blood cells
- Check lipids every 4-6 weeks on cycle
- Monitor liver enzymes every 2-4 weeks with oral compounds
- Discontinue if liver enzymes exceed 3x upper limit
Cycle Duration
- Limit oral steroid cycles to 6-8 weeks maximum
- Allow time off equal to or greater than cycle length
- Full HPTA recovery can take 3-12 months
- Higher doses exponentially increase adverse effects
- Monitor blood pressure weekly during cycles
PCT Requirements
- Always include post-cycle therapy in planning
- SERMs restore testosterone in 70-80% of cases
- Consider HCG during cycle for easier recovery
- Monitor LH and FSH during and after cycle
- Recovery timeline varies - be patient with bloodwork
Risk Factors
Cardiovascular
Blood pressure, cholesterol, and heart health
Risks
- Blood pressure elevation in 15-20% of users
- HDL reduction by 20-40% with oral steroids
- Increased heart attack risk in first 90 days
- Left ventricular hypertrophy with long-term use
Mitigation
- Monitor BP weekly; medicate if systolic >140
- Avoid with pre-existing cardiovascular disease
- Regular lipid monitoring every 4-6 weeks
- Annual echocardiogram after 2+ years of use
Hepatotoxicity
Liver stress from 17-alpha-alkylated orals
Risks
- 50-80% of users show enzyme elevation
- 1-3% develop serious complications
- Risk increases beyond 6-8 weeks
- ALT/AST typically 2-5x normal range
Mitigation
- Limit oral cycles to 6-8 weeks
- Monitor ALT/AST every 2-4 weeks
- Discontinue if enzymes exceed 3x limit
HPTA Suppression
Natural testosterone production shutdown
Risks
- 90-95% suppression within 2-4 weeks
- Dose-dependent suppression severity
- Recovery takes 3-12 months without PCT
- Longer cycles require longer recovery
Mitigation
- Always use testosterone base
- Include proper PCT protocol
- Allow adequate time off between cycles
- Consider HCG to maintain testicular function
Special Considerations
Testosterone Base RequirementMale-Specific
Why testosterone base is essential for harm reduction
Why It Matters
- All AAS suppress HPTA within 2-6 weeks
- Prevents hypogonadal symptoms
- Maintains basic physiological function
- Makes PCT more effective
Common Options (100-200mg/week)
Long ester, inject 1-2x weekly
Short ester, more frequent injections
Female ConsiderationsCritical
Female protocols differ fundamentally from male protocols
Why Testosterone is NOT Used
- Women produce only 0.3-0.4mg/day vs 6-7mg in men
- 15-20x more sensitive to androgens
- Voice deepening is often IRREVERSIBLE
- Traditional PCT is NOT required for women
Irreversible Virilization Effects:
Voice deepening, clitoral enlargement, male-pattern hair growth. STOP IMMEDIATELY at first signs.
Research Library
Peer-reviewed studies supporting these guidelines
Testosterone Therapy in Older Men with Mobility Limitations
Basaria S, et al. / New England Journal of Medicine
Testosterone therapy associated with increased cardiovascular events. Study stopped early due to safety concerns.
Association of Testosterone Therapy With Mortality, MI, and Stroke
Vigen R, et al. / JAMA
In 8,709 men over 3 years, testosterone therapy associated with increased cardiovascular risk.
Long-Term AAS Use and Left Ventricular Dysfunction
Baggish AL, et al. / Circulation: Heart Failure
Long-term AAS use (>2 years) associated with reduced left ventricular function.
Important Safety Notice
This information is compiled from peer-reviewed research for harm reduction purposes. It does not constitute medical advice. Individual responses vary significantly. Always consult with qualified healthcare professionals before making any health decisions.